MedPath

Keranetics, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Skin Prick Test of KeraStat® Cream

Not Applicable
Completed
Conditions
Hypersensitivity
Interventions
Device: Biafine
Device: KeraStat Gel
Drug: Saline (0.9% NaCl)
Device: KeraStat® Cream
First Posted Date
2019-08-15
Last Posted Date
2022-11-15
Lead Sponsor
KeraNetics, LLC
Target Recruit Count
22
Registration Number
NCT04058054
Locations
🇺🇸

PMG Research, Inc., Winston-Salem, North Carolina, United States

Effectiveness of KeraStat Gel for Improved Cosmesis of Partial Thickness Burns

Not Applicable
Terminated
Conditions
Partial-thickness Burn
First Posted Date
2018-06-21
Last Posted Date
2024-08-01
Lead Sponsor
KeraNetics, LLC
Target Recruit Count
14
Registration Number
NCT03564795
Locations
🇺🇸

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

KeraStat(R) Cream for Radiation Dermatitis

Not Applicable
Completed
Conditions
Radiation Dermatitis
First Posted Date
2018-06-18
Last Posted Date
2021-09-09
Lead Sponsor
KeraNetics, LLC
Target Recruit Count
25
Registration Number
NCT03559218
Locations
🇺🇸

Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.